Healthcare providers (hospitals, clinics) are the largest end‑user segment — they use analytics for patient care, population health, and operational efficiency. But pharmaceutical companies are the fastest‑growing. The US clinical data analytics market research study shows that pharma is growing at over 12% CAGR, because they're using analytics to identify new drug targets, run virtual clinical trials, and personalise marketing.

What's driving pharma adoption? The explosion of real‑world data (RWD) — insurance claims, electronic health records, and even wearable data. The US clinical data analytics market trends highlight that the fastest‑growing component is services (consulting, implementation), as healthcare organisations struggle to hire data scientists.

But pharma faces a challenge: data silos. Patient data is scattered across different hospitals, payers, and labs. That's why partnerships with health systems are essential.

The message: if you're a pharma company, don't go it alone. Collaborate with data partners. And if you're a provider, monetise your data — but protect patient privacy.